Clinical Trial Update: Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of sulindac and docetaxel for metastatic or recurrent breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Sulindac (sulindac)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED